The development of dysbiosis in NLRP6-deficient mice resulted in exacerbation of chemical colitis induced by exposure to dextran sodium sulfate [87], colitis-associated colorectal cancer [88], and features of the metabolic syndrome, including non-alcoholic fatty liver disease, morbid obesity, and type II diabetes mellitus [89]. Here, NLRP6 is linked to colitis.